BPG致力于知识发现和传播
Articles Published Processes
2019/4/8 12:10:35 | Browse: 636 | 下载: 637
| Publication Name |
世界华人消化杂志 |
| 手稿编号 |
36677 |
| 手稿来源省、自治区或特别行政区 |
广西壮族自治区 |
 |
Received |
|
2018-12-27 07:40 |
|
Peer-Review Started |
|
2018-12-28 02:30 |
|
To Make the First Decision |
|
2019-01-09 02:52 |
|
Return for Revision |
|
2019-01-15 07:29 |
|
修回稿 |
|
2019-01-22 06:54 |
|
Second Decision |
|
2019-03-15 07:13 |
 |
期刊总编辑接受 |
|
|
|
公司总编辑接受 |
|
2019-03-16 04:11 |
|
预出版 |
|
2019-03-16 04:11 |
|
缴纳版面费 |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
排版 |
|
2019-04-04 04:40 |
|
在线出版 |
|
2019-04-08 12:10 |
| ISSN |
1009-3079 (print) and 2219-2859 (online) |
| 开放获取 |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| 版权 |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| 网址 |
http://www.wjgnet.com |
| 专业类型 |
消化肿瘤学 |
| 手稿栏目类型 |
文献综述 |
| 文章标题 |
原发性肝癌靶向药物治疗试验与临床研究进展
|
| 手稿来源 |
自由来稿 |
| 所有作者列表 |
杨哲, 李建基, 黄赞松 |
| ORCID |
|
| 基金项目及其编号 |
| 基金项目名称 |
基金编号 |
| 广西自然科学基金资助项目 |
No.桂财教2014GXNSFAA118143 |
| 广西科技基地与人才专项（广西肝胆疾病临床医学研究中心研究课题） |
No.桂科AD17129035 |
| 广西医药卫生自筹经费计划课题 |
No.桂卫Z20170224 |
|
| 通讯作者 |
黄赞松, 研究生, 教授, 主任医师, 533000, 广西壮族自治区百色市右江区中山二路18号, 右江民族医学院附属医院消化内科. 1019846481@qq.com |
| 关键词 |
原发性肝癌; 靶向药物; 治疗试验; 临床研究 |
| 核心内容提要 |
自索拉非尼问世后, 靶向治疗成为肝癌治疗的热点, 许多研究相继开展, 但均未取得明显效果. 近两年肝癌靶向药物有较大进展, 出现了新的一线及二线肝癌靶向药物, 逐渐成为新的治疗方向, 在未来有极大的发展潜力. |
| 出版日期 |
2019-04-08 12:10 |
| 引文著录 |
杨哲, 李建基, 黄赞松. 原发性肝癌靶向药物治疗试验与临床研究进展. 世界华人消化杂志 2019 |
| URL |
https://www.wjgnet.com/1009-3079/full/v27/i7/450.htm |
| DOI |
https://dx.doi.org/10.11569/wcjd.v27.i7.450 |
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
